Fierce Biotech · 23 Oct, 03:36 · Technology briefing

Treasury sweeps biotech into proposed COINS Act restrictions, but spares Big Pharma’s China licensing deals

The US Treasury has included biotechnology within the proposed COINS Act restrictions, significantly tightening regulations on foreign investments in this sector.

What it means for you ↓ Courses for this story

30%premium for professionals who pair domain skills with tech fluency

3.5xfaster skill turnover — staying current is the moat

74%of employers fund staff who self-start upskilling

20days to your first credential

The briefing

The story
in brief.

What happened, who it affects, and why it landed on our intelligence desk — in plain English, sixty seconds or less.

The US Treasury has included biotechnology within the proposed COINS Act restrictions, significantly tightening regulations on foreign investments in this sector. However, the proposal explicitly exempts large pharmaceutical companies from these constraints regarding their licensing agreements with Chinese entities. This distinction creates a divergent regulatory landscape, imposing stricter compliance burdens on smaller biotech firms while allowing established Big Pharma to maintain existing cross-border partnerships. Professionals in the life sciences sector must now navigate this complex legal environment, where investment flows and collaborative opportunities are increasingly dictated by political policy rather than purely commercial merit.

Employer demand for Medical Physics skills — indexed growth since 2019
Indicative index of skill mentions in professional job postings for the field this story moves (2019 = 1)

Your move

What this means
for your career.

Every headline redistributes opportunity. Here is who this one rewards — and how to be on the right side of it.

You must now prioritise regulatory acumen alongside your technical expertise. If you work in biotech, compliance and governance skills are becoming critical differentiators for career advancement. Big Pharma professionals should focus on cross-border licensing strategies and international partnership management. To stay ahead, you should immediately upskill in navigating US export controls and investment screening mechanisms. Understand the specific legal distinctions between biotech startups and pharmaceutical giants. A smart professional would analyse how these restrictions affect their organisation’s supply chain and investment pipeline. Prepare to advise stakeholders on risk mitigation and alternative market entry strategies. Mastery of these regulatory nuances will position you as an indispensable asset in an increasingly polarised global healthcare landscape.

For this story, the fields that convert it into pay are Medical Physics, Python Data Visualisation Libraries Mastery, API Development and Staff Recruitment And Retention — exactly the programmes matched below. The chart shows the indicative salary uplift certified professionals report in each of those fields; every one of them is a click away, from £79, finishing in as few as 20 days.

Indicative salary uplift in the fields matched to this story
Indicative ranges from published continuing-education salary studies, by field — each field is a recommended course below

Matched to this story

Enrol in these
to benefit.

These programmes position you for exactly this shift — online, self-paced, and finishing with a verifiable certificate you can share the day you pass.